Publicações Científicas 2024 - Junho

1. Pollock NR, Farias TDJ, Kichula KM, Sauter J, Scholz S, Nii-Trebi NI, et al. The 18th International HLA & Immunogenetics workshop project report: Creating fully representative MHC reference haplotypes. Hla. 2024;103(6):e15568. 10.1111/tan.15568.

2. Martins OC, Antunes do Livramento VJ, Florêncio de Mesquita C, Correa TL, Fernandes MV, Milioli NJ, et al. The Addition of Endoscopic Sphincterotomy to Biliary Stent Placement and its Impact on the Risk of Adverse Events: An Updated Meta-Analysis of Randomized Controlled Trials. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.05.014.

3. Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, et al. Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. N Engl J Med. 2024. 10.1056/NEJMoa2403614.

4. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2024;281(1):351-7. 10.1007/s00405-023-08180-w.

5. Monteiro MR, Nunes NCC, Junior A, Fêde ABS, Bretas GO, Souza CP, et al. Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast Cancer (Dove Med Press). 2024;16:51-70. 10.2147/bctt.S448191.

6. Borges CDJ, Alfonso Rodriguez Elvir F, Silva Santana L, Michaela de Oliveira H, Laura Lima Larcipretti A, Muniz Vieira de Melo T, et al. Asleep versus awake GPi DBS surgery for Parkinson’s disease: A systematic review and meta-analysis. J Clin Neurosci. 2024;123:196-202. 10.1016/j.jocn.2024.03.033.

7. Reis MT, Matsushita M, Santos W, de Lima MA, Guimarães DP, Reis RM. Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer. Surgical Experimental Pathology. 2024;7(1):1. 10.1186/s42047-024-00144-6.

8. Pirola WE, Barroso EM, Gama RR, dos Santos Neto MF, Teodoro VA, da Silva Tozzo FCB, et al. Association between periodontal disease and breast cancer: systematic review and meta-analysis. Revista Eletrônica Acervo Saúde. 2024;24(2):e15386-e. 10.25248/reas.e15386.2024.

9. Vince CSC, Brassesco MS, Mançano BM, Gregianin LJ, Carbone EK, do Amaral ECA, et al. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology. JCO Precis Oncol. 2024;8:e2300713. 10.1200/po.23.00713.

10. Casali BC, Baptista MP, Pachane BC, Cortez AA, Altei WF, Selistre-de-Araújo HS. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity. Biochem Biophys Rep. 2024;38:101686. 10.1016/j.bbrep.2024.101686.

11. Lobo MM, Wainstein AJA, Barros AV, Oliveira AF, Jafelicci AS, Molina AS, et al. Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment. J Surg Oncol. 2024. 10.1002/jso.27728.

12. Bugano DDG, Santos VM, Campos-Bragagnoli A, Melo JCM, Romagnolo LGC, Barbosa Neto O, et al. Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer. Clin Colorectal Cancer. 2024. 10.1016/j.clcc.2024.03.003.

13. Buralli R, Ribeiro A, Cremonese C, Vineis P, Meyer A. Cancer mortality and premature deaths among hairdressers in Brazil. Environ Res. 2024;244:117942. 10.1016/j.envres.2023.117942.

14. Dutra JPP, Macedo AVS, Peixoto T, Garcez JDS, Bacchiega BC, Marchi P, et al. Cardiology and oncology: a meeting of giants. Rev Assoc Med Bras (1992). 2024;70(suppl 1):e2024S114. 10.1590/1806-9282.2024s114.

15. Gouveia AG, Viani GA, Bratti VF, Marta GN, Hanna SA, Jacinto AA, et al. Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion plan. J Cancer Policy. 2024;39:100459. 10.1016/j.jcpo.2023.100459.

16. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2024;29(2):e296-e7. 10.1093/oncolo/oyad284.

17. Aguiar Freitas AJ, Nunes CR, Mano MS, Causin RL, Calfa S, de Oliveira MA, et al. Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial. Future Oncol. 2024;20(1):25-38. 10.2217/fon-2023-0886.

18. Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Gonçalves SM, Mendes-Alves C, et al. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers (Basel). 2024;16(7). 10.3390/cancers16071418.

19. Arruda do Espirito Santo P, Meine GC, Baraldo S, Barbosa EC. Cold endoscopic mucosal resection versus cold snare polypectomy for colorectal lesions: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024. 10.1055/a-2275-5349.

20. Syrjänen K, Eskelinen M, Meklin J, Hendolin P, Eskelinen M, Suovaniemi O. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB). Anticancer Res. 2024;44(4):1513-23. 10.21873/anticanres.16948.

21. Santarosa Vieira AG, da Silva LS, Albino da Silva EC, Laus AC, Faria TMV, van Helvoort Lengert A, et al. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures. Mol Oncol. 2024;18(6):1593-607. 10.1002/1878-0261.13617.

22. Simione AJ, das Neves HRA, da Silva CC, da Silva Sabaini PM, Geraldo BLdSS, Pasquini M, et al. Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides – 2024anderson. Journal of Bone Marrow Transplantation Cellular Therapy. 2022;3(2):171-.

23. Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Kozesinski-Nakatani AC, et al. Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial. Jama. 2024. 10.1001/jama.2024.10510.

24. Bednar EM, Paiz KA, Lu KH, Soares Dias De Souza AP, Oliveira G, Andrade C, et al. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico. Int J Gynecol Cancer. 2024. 10.1136/ijgc-2023-005190.

25. Birolli WG, Lanças FM, dos Santos Neto ÁJ, Silveira HC. Determination of pesticide residues in urine by chromatography-mass spectrometry: methods and applications. Frontiers in Public Health. 2024;12:1336014. 10.3389/fpubh.2024.1336014.

26. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA. Anticancer Res. 2024;44(1):173-84. 10.21873/anticanres.16800.

27. Scuglia M, Frazão LP, Miranda A, Martins A, Barbosa-Sequeira J, Coimbra D, et al. Diaphragmatic hernia repair porcine model to compare the performance of biodegradable membranes against Gore-Tex(®). Pediatr Surg Int. 2024;40(1):7. 10.1007/s00383-023-05584-x.

28. da Costa Vieira RA, Facina G, Tiezzi DG, Urban CA, de Freitas Junior R. Editorial: Oncoplastic surgery for breast cancer. Front Oncol. 2024;13:1348964. 10.3389/fonc.2023.1348964.

29. de Araújo TBS, Nogueira RLR, Siquara da Rocha LO, Bastos IN, Dias RB, Souza BSF, et al. Enhancing scaffold-free spheroid models: 3D cell bioprinting method for metastatic HSC3-Oral squamous carcinoma cell line. SLAS Discov. 2024;29(4):100158. 10.1016/j.slasd.2024.100158.

30. Rohr P, Karen S, Francisco LFV, Oliveira MA, Dos Santos Neto MF, Silveira HCS. Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis. Environ Epigenet. 2024;10(1):dvae005. 10.1093/eep/dvae005.

31. Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, et al. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024. 10.1007/s13577-024-01054-1.

32. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2024;35(3):523-9. 10.1007/s10552-023-01812-w.

33. Barbosa EC, Santo P, Baraldo S, Nau AL, Meine GC. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: A systematic review and meta-analysis of randomized controlled trials. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.04.019.

34. Wood A, Pereira A, Araújo E, Ferigatto J, Buexm L, Barroso E, et al. Evaluation of the Impact of Oral Health on the Daily Activities of Users of the National Health System. Int J Environ Res Public Health. 2024;21(1). 10.3390/ijerph21010092.

35. Reid F, Adams T, Adel RS, Andrade CE, Bajwa A, Bambury IG, et al. The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer. PLoS One. 2024;19(5):e0298154. 10.1371/journal.pone.0298154.

36. Vieira IA, Viola GD, Pezzi EH, Kowalski TW, Fernandes BV, Andreis TF, et al. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas. Genet Mol Biol. 2024;46(3 Suppl 1):e20230133. 10.1590/1678-4685-gmb-2023-0133.

37. Vieira R, Paulinelli RR, de Oliveira-Junior I. Extreme oncoplasty: past, present and future. Front Oncol. 2024;13:1215284. 10.3389/fonc.2023.1215284.

38. Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. J Clin Oncol. 2024:Jco2301601. 10.1200/jco.23.01601.

39. Palavani LB, Silva GM, Borges P, Ferreira MY, Sousa MP, Leite M, et al. Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis. J Neurooncol. 2024. 10.1007/s11060-024-04621-6.

40. Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, et al. Functional pri-miR-34b/c rs4938723 and KRAS 3’UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome? Gene. 2024;898:148069. 10.1016/j.gene.2023.148069.

41. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2024;39:101818. 10.1016/j.tranon.2023.101818.

42. Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 2024;629(8013):910-8. 10.1038/s41586-024-07368-2.

43. Pereira-Vieira J, Weber DD, Silva S, Barbosa-Matos C, Granja S, Reis RM, et al. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. J Pharmaceutics. 2024;16(4):442. 10.3390/pharmaceutics16040442.

44. Paiva BSR, Mingardi M, de Almeida LF, de Camargos MG, Valentino TCO, Julião M, et al. Go Wish card game-exploring end-of-life wishes of patients in oncology palliative care: a qualitative study. Ann Palliat Med. 2024;13(1):31-41. 10.21037/apm-23-381.

45. Custódio IDD, Nunes FSM, Lima MTM, Carvalho KP, Machado AM, Lajolo PP, et al. Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy. Clinics (Sao Paulo). 2024;79:100324. 10.1016/j.clinsp.2024.100324.

46. Ferreira J, Roque S, Longatto-Filho A, Afonso J, Carneiro A, Vila I, et al. Higher levels of cytokines in patients with critical limb threatening ischemia. Ann Vasc Surg. 2024. 10.1016/j.avsg.2024.02.033.

47. Campacci N, Grasel RS, Galvão HCR, Garcia LF, Ribeiro PC, Pereira K, et al. The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing? Front Psychol. 2024;15:1306388. 10.3389/fpsyg.2024.1306388.

48. González-Cao M, Cai X, Bracht JWP, Han X, Yang Y, Pedraz-Valdunciel C, et al. HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer. Lung Cancer (Auckl). 2024;15:55-67. 10.2147/lctt.S455034.

49. Sorroche BP, Miranda KC, Beltrami CM, Arantes L, Kowalski LP, Marchi FA, et al. HOXA1 3’UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers (Basel). 2024;16(5). 10.3390/cancers16050874.

50. Bernardi FDC, Algranti E, Dolhnikoff M, Pinto CAL, Oliveira IM, Coletta E, et al. Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil. J Bras Pneumol. 2024;50(2):e20230343. 10.36416/1806-3756/e20230343.

51. Zucca LER, Laus AC, Sorroche BP, Paro E, Sussuchi L, Marques RF, et al. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer. Transl Oncol. 2024;46:102003. 10.1016/j.tranon.2024.102003.

52. Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, Zambuzi-Roberto FA, Pereira CAD, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res. 2024. 10.1097/cmr.0000000000000958.

53. Singer S, Sykiotis G, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, et al. The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients. Endocrine. 2024;84(2):635-45. 10.1007/s12020-023-03628-9.

54. Vianna FSL, Neves LL, Testa R, Nassar AP, Jr., Peres JHF, da Silva RÁ J, et al. Impact of the COVID-19 Pandemic on the Outcomes of Patients Undergoing Oncological Surgeries: CORONAL Study. Ann Surg Oncol. 2024. 10.1245/s10434-024-15152-9.

55. Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer OL, et al. Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial. JCO Glob Oncol. 2024;10:e2300216. 10.1200/go.23.00216.

56. Carvalho L, de Lima FP, Cerqueira M, Silva A, Pontes O, Oliveira-Pinto S, et al. In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC Med Chem. 2024;15(4):1362-80. 10.1039/d3md00682d.

57. Veiga VC, Peres SV, Ostolin T, Moraes FR, Belucci TR, Clara CA, et al. Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis. PLoS One. 2024;19(6):e0304682. 10.1371/journal.pone.0304682.

58. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2024;166(1):215. 10.1053/j.gastro.2023.05.011.

59. Vieira TDS, Freitas FV, Silva Neto LCB, Borçoi AR, Barbosa WM, Olinda AS, et al. An industrialized diet as a determinant of methylation in the 1F region of the NR3C1 gene promoter. Frontiers in Nutrition. 2024;11:1168715. 10.3389/fnut.2024.1168715.

60. Ferreira J, Afonso J, Longatto-Filho A, Roque S, Carneiro A, Vila I, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2024;99:10-8. 10.1016/j.avsg.2023.09.094.

61. Ferreira J, Longatto-Filho A, Afonso J, Roque S, Carneiro AL, Vila I, et al. Inflammatory Cells in Adipose Tissue and Skeletal Muscle of Patients with Peripheral Arterial Disease or Chronic Venous Disease: A Prospective, Observational, and Histological Study. J Cardiovasc Dev Dis. 2024;11(4). 10.3390/jcdd11040121.

62. Riedmeier M, Antonini SRR, Brandalise S, Costa T, Daiggi CM, de Figueiredo BC, et al. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. Eur J Endocrinol. 2024;190(4):G15-g24. 10.1093/ejendo/lvae038.

63. Patrón Uriburu JC, Araujo S, Mario A, Billy J, Méndez R, Rossi G, et al. Intracorporeal anastomosis could be associated with a higher lymph node yield in right colon cancer surgery: Results of the ICA-LATAM study, a retrospective, multicentre, comparative analysis in Latin America. Colorectal Dis. 2024;26(5):940-8. 10.1111/codi.16962.

64. Cappellano AM, Dassi N, Mançano BM, Epelman S, Almeida DB, Cavalheiro S, et al. Intracranial non-germinomatous germ cell tumors in children and adolescents: how can the experience from an uppermiddle-income country contribute to the worldwide effort to improve outcomes? Front Oncol. 2024;14:1308128. 10.3389/fonc.2024.1308128.

65. de Arruda JAA, Oliveira SR, Heimlich FV, de Amorim-Santos BM, Schneider AH, de Sena A, et al. Kinetics of neutrophil extracellular traps and cytokines in oral mucositis and Candida infection. Oral Dis. 2024. 10.1111/odi.14857.

66. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al. Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 2024;10:e2300343. 10.1200/go.23.00343.

67. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study. Int J Cancer. 2024. 10.1002/ijc.34861.

68. Paiva CE, Zonta MPM, Granero RC, Guimarães VS, Pimenta LM, Teixeira GR, et al. The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients. Cancers (Basel). 2024;16(2). 10.3390/cancers16020339.

69. Faria EF, Maciel CVM, Melo PA, Tobias-Machado M, Dias RM, Dos Reis RB, et al. Mesentery-Sparing Technique: a New Intracorporeal Approach for Urinary Diversion in Robot-Assisted Radical Cystectomy. Int Braz J Urol. 2024;50(4):489-99. 10.1590/s1677-5538.Ibju.2024.0153.

70. Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. 10.1002/jev2.12404.

71. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024. 10.1038/s41588-024-01725-7.

72. Brenes D, Salcedo MP, Coole JB, Maker Y, Kortum A, Schwarz RA, et al. Multiscale Optical Imaging Fusion for Cervical Precancer Diagnosis: Integrating Widefield Colposcopy and High-Resolution Endomicroscopy. IEEE Trans Biomed Eng. 2024;Pp. 10.1109/tbme.2024.3379898.

73. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 2024:100500. 10.1016/j.xgen.2024.100500.

74. Stelet VN, Romero M, Cita RF, Binato R, Abdelhay E. A novel HLA-C*02:10 variant, HLA-C*02:10:09, identified in a healthy individual from Brazil. Hla. 2024;103(2):e15410. 10.1111/tan.15410.

75. Vazquez FL, Coracin FL, Arantes K, Ferigatto JL, Nascimento-Júnior AC, Barroso EM, et al. An oral cancer screening program in Brazil: Analysis of seven years of outcome after its implementation in the suburban cities of São Paulo. Oral Oncol. 2024;154:106826. 10.1016/j.oraloncology.2024.106826.

76. Santos FA, Reis RM, Barroti LC, Pereira AAL, Matsushita MM, de Carvalho AC, et al. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. J Gastrointest Cancer. 2024;55(1):344-54. 10.1007/s12029-023-00964-x.

77. Junior JNA, Preto DD, Lazarini M, de Lima MA, Bonatelli M, Berardinelli GN, et al. PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site. Int J Clin Oncol. 2024. 10.1007/s10147-024-02494-3.

78. Ferreira J, Longatto-Filho A, Dionísio A, Correia-Neves M, Cunha P, Mansilha A. Peri-Carotid Adipose Tissue and Atherosclerosis at Carotid Bifurcation. J Cardiovasc Dev Dis. 2024;11(2). 10.3390/jcdd11020058.

79. Hui D, Cheng SY, Paiva CE. Pharmacologic Management of End-of-Life Delirium: Translating Evidence into Practice. Cancers (Basel). 2024;16(11). 10.3390/cancers16112045.

80. Fontes MS, de Almeida DVP, Cárcano F, Lages P, Dienstmann R. Precision medicine for urothelial carcinoma: An international perspective. Urol Oncol. 2024. 10.1016/j.urolonc.2023.11.008.

81. de Barros ESPGM, Furtado RHM, de Alcântara Chaud MS, Macedo AVS, Bronhara B, Damiani LP, et al. Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial. J Thromb Thrombolysis. 2024. 10.1007/s11239-024-02995-y.

82. McNeil MJ, Garcia Quintero X, Gonzalez M, Zheng Y, Ugaz Olivares C, Morales R, et al. Preventing and Treating Pain and Anxiety during Needle-Based Procedures in Children with Cancer in Low- and Middle-Income Countries. Cancers (Basel). 2024;16(5). 10.3390/cancers16051025.

83. Maia IS, Medrado FA, Jr., Tramujas L, Tomazini BM, Oliveira JS, Sady ERR, et al. Prospective, randomized, controlled trial assessing the effects of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome due to community-acquired pneumonia (STAMINA trial): protocol and statistical analysis plan. Crit Care Sci. 2024;36:e20240210en. 10.62675/2965-2774.20240210-en.

84. Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024. 10.1016/j.bja.2024.02.005.

85. Diniz JBC, Alfonso Rodriguez Elvir F, Silva Santana L, Batista S, Glioche Gasparri L, Mota Telles JP, et al. Replacement of traditional vagus nerve stimulation with cardiac-based device and seizure reduction: A systematic review and meta-analysis. Seizure. 2024;118:65-70. 10.1016/j.seizure.2024.04.001.

86. Lima JA, Sorroche BP, Tostes K, Dias TC, de Carvalho Rodrigues N, Tansini A, et al. Repurposing discarded leukodepletion filters as a source of mononuclear cells for advanced in vitro research. J Immunol Methods. 2024;530:113694. 10.1016/j.jim.2024.113694.

87. Arias AV, Lintner-Rivera M, Shafi NI, Abbas Q, Abdelhafeez AH, Ali M, et al. A research definition and framework for acute paediatric critical illness across resource-variable settings: a modified Delphi consensus. Lancet Glob Health. 2024;12(2):e331-e40. 10.1016/s2214-109x(23)00537-5.

88. Ferreira J, Roque S, Lima Carneiro A, Longatto-Filho A, Vila IN, Cunha C, et al. Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia. J Am Heart Assoc. 2024;13(8):e031922. 10.1161/jaha.123.031922.

89. Groisman Sieben R, Paternina-de la Ossa R, Waack A, Casale Aragon D, Bellissimo-Rodrigues F, Israel do Prado S, et al. Risk factors and mortality of candidemia in a children’s public hospital in Sao Paulo, Brazil. Rev Argent Microbiol. 2024. 10.1016/j.ram.2023.09.002.

90. Kremer V, Oliveira Junior WE. The role of Pediatric Surgery in childhood cancer. Rev Assoc Med Bras (1992). 2024;70(suppl 1):e2024S110. 10.1590/1806-9282.2024s110.

91. Ubinha ACF, Pedrão PG, Tadini AC, Schmidt RL, Santos MHD, Andrade C, et al. The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature. Cancers (Basel). 2024;16(4). 10.3390/cancers16040817.

92. Vázquez-Iglesias L, Stanfoca Casagrande GM, García-Lojo D, Ferro Leal L, Ngo TA, Pérez-Juste J, et al. SERS sensing for cancer biomarker: Approaches and directions. Bioact Mater. 2024;34:248-68. 10.1016/j.bioactmat.2023.12.018.

93. Barateiro L, de Oliveira Cavagna R, Dos Reis MB, de Paula FE, Teixeira GR, Moreno DA, et al. Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine. Neuropathology. 2024. 10.1111/neup.12979.

94. Rabelo BS, de Alvarenga KAF, Fernando Lopes L, Guimarães Ribeiro A, de Sá Rodrigues KE. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review. Pediatr Blood Cancer. 2024;71(7):e30987. 10.1002/pbc.30987.

95. Ferreira MY, Thomaz de Assis EB, Batista S, Palavani LB, Verly G, Corrêa EM, et al. Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. 10.1016/j.wneu.2024.01.006.

96. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2024;90(1):13-24. 10.1055/a-2181-2569.

97. Chavan R, Baraldo S, Patel N, Gandhi C, Rajput S. Technical tips for EUS-guided embolization of varices and pseudoaneurysms. VideoGIE. 2024;9(4):211-9. 10.1016/j.vgie.2023.12.006.

98. Ebel L, Autrán AM, Rodríguez-Faba O, Alcántara C. Testicular cancer in Ibero-America: Proper prevention and diagnostic strategies. Actas Urol Esp (Engl Ed). 2024. 10.1016/j.acuroe.2024.06.002.

99. Carvalho BF, Gomez GVB, Carron J, Macedo LT, Gonçalves GM, Vazquez VL, et al. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma. Int J Mol Sci. 2024;25(5). 10.3390/ijms25052868.

100. Palavani LB, Ferreira MY, Borges P, Bandeira L, da Silva Semione G, Almeida MV, et al. Ultrasound-Guided Resection of High-Grade Gliomas: A Single-Arm Meta-Analysis. World Neurosurg. 2024;186:17-26. 10.1016/j.wneu.2024.03.033.

101. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2024;906:167393. 10.1016/j.scitotenv.2023.167393.

102. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Neurooncol Adv. 2024;6(1):vdad140. 10.1093/noajnl/vdad140.

103. Cardoso-Carneiro D, Pinheiro J, Fontão P, Nogueira R, Gabriela-Freitas M, Raquel-Cunha A, et al. Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer. Cancers (Basel). 2024;16(12):2182. 10.3390/cancers16122182.

104. Arantes L, Silva-Oliveira RJ, de Carvalho AC, Melendez ME, Sorroche BP, de Jesus Teixeira R, et al. Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. Head Neck. 2024;46(3):461-72. 10.1002/hed.27602.

105. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2024;20(1):133.e1-.e9. 10.1016/j.jpurol.2023.10.014.

106. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2024;22(2):387-95. 10.1017/s1478951523001517.